Physician profile
Dennis Brenner
NPI 1467487512
$38,783.41
in general payments reported to CMS, 2019-2025
48 companies · $15K in 2025
The $15K reported for 2025 was more than what 91% of Pediatric Endocrinology providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,109 · 2020: $592 · 2021: $599 · 2022: $794 · 2023: $11K · 2024: $9,956 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,600 · Food and Beverage: $5,536 · Travel and Lodging: $3,349 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,171.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,600.00 |
| Food and Beverage | $5,535.98 |
| Travel and Lodging | $3,349.37 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $10,496.87 | 2023-2025 | |
| Ascendis Pharma Endocrinology INC | $8,942.56 | 2022-2025 | Skytrofa |
| Neurocrine Biosciences, INC. | $5,536.82 | 2023-2025 | |
| Pfizer INC. | $5,193.11 | 2019-2025 | |
| Biomarin Pharmaceutical INC. | $3,281.65 | 2023-2025 | Voxzogo 1.2mg |
| Novo Nordisk INC | $1,130.17 | 2019-2025 | Sogroya, Norditropin |
| Abbvie INC. | $710.80 | 2019-2025 | Lupron Depot |
| Insulet Corporation | $346.03 | 2019-2024 | Omnipod |
| Lilly USA, LLC | $288.96 | 2020-2023 | Baqsimi |
| Tandem Diabetes Care, INC. | $239.25 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ipsen Biopharmaceuticals, INC | $235.88 | 2019-2025 | Increlex, Bylvay |
| Alexion Pharmaceuticals, INC. | $227.46 | 2019-2025 | Strensiq |
| Dexcom, INC. | $193.49 | 2019-2025 | Dexcom G6 Transmitter |
| Endo Pharmaceuticals INC. | $182.88 | 2019-2023 | Supprelin |
| Tolmar, INC. | $164.87 | 2023-2025 | Fensolvi |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $143.88 | 2023-2025 | Crysvita |
| Abbott Laboratories | $123.95 | 2020-2024 | Freestyle Libre 3 |
| Azurity Pharmaceuticals, INC. | $117.18 | 2023-2025 | Triptodur, Xatmep, Triptodur |
| Medtronic, INC. | $113.26 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Xeris Pharmaceuticals, INC. | $90.39 | 2020-2023 | Gvoke Hypopen |
| Arbor Pharmaceuticals, INC. | $88.07 | 2019-2022 | |
| Rhythm Pharmaceuticals, INC. | $84.68 | 2021-2025 | Imcivree |
| Antares Pharma, INC. | $74.04 | 2020-2021 | |
| Tolmar Pharmaceuticals, INC. | $73.05 | 2021-2022 | |
| Medtronic Minimed, INC. | $61.71 | 2019-2020 | |
| Sandoz INC. | $56.01 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $54.80 | 2019-2020 | |
| Endo USA, INC. | $54.25 | 2024-2025 | Supprelin |
| Amphastar Pharmaceuticals, INC. | $51.63 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.15 | 2025 | Eohilia |
| Ibsa Pharma INC. | $42.43 | 2019-2023 | Tirosint, Licart |
| Jazz Pharmaceuticals INC. | $30.20 | 2023-2024 | |
| Ultragenyx Pharmaceutical INC. | $30.03 | 2020-2022 | |
| Becton, Dickinson and Company | $29.80 | 2019 | |
| Zealand Pharma US, INC. | $25.65 | 2021-2022 | |
| Kadmon Pharmaceuticals LLC | $23.09 | 2019 | |
| Beta Bionics, INC. | $22.13 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Sequel Med Tech, LLC | $20.18 | 2025 | Twiist |
| Philips North America LLC | $19.96 | 2022 | |
| Mirum Pharmaceuticals, INC. | $18.46 | 2025 | Cholbam |
| Harmony Biosciences LLC | $18.27 | 2025 | |
| Travere Therapeutics, INC. | $17.37 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $16.99 | 2024 | |
| Amgen INC. | $15.00 | 2019 | |
| Amryt Pharma Holdings LTD | $14.29 | 2021 | |
| Eton Pharmaceuticals, INC. | $13.61 | 2023 | Alkindi |
| Covis Pharma Gmbh | $12.97 | 2019 | |
| Amneal Pharmaceuticals LLC | $12.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Brenner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.